Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.

[1]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[2]  S. Dower,et al.  Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. , 1995, Blood.

[3]  T. Herzog,et al.  Evidence for a protein synthesis-dependent and -independent TNF alpha cytolytic mechanism. , 1995, Gynecologic oncology.

[4]  M. Takemura,et al.  Highly sensitive ELISA for soluble Fas in serum: increased soluble Fas in the elderly. , 1996, Clinical chemistry.

[5]  Matthew J. Brauer,et al.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.

[6]  N. Copeland,et al.  The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. , 1992, Journal of immunology.

[7]  J. McMurray,et al.  Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. , 1991, British heart journal.

[8]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[9]  A. Wyllie,et al.  Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis , 1984, The Journal of pathology.

[10]  Y. Hayakawa,et al.  Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. , 1996, Circulation.

[11]  T. Herzog,et al.  Evidence for a Protein Synthesis-Dependent and -Independent TNFα Cytolytic Mechanism , 1995 .

[12]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[13]  R. Kloner,et al.  Reperfusion injury induces apoptosis in rabbit cardiomyocytes. , 1994, The Journal of clinical investigation.

[14]  田中 正人.  Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes , 1995 .

[15]  J. Cohen,et al.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. , 1984, Journal of immunology.

[16]  T. Yokota,et al.  Expression of the Fas ligand in cells of T cell lineage. , 1995, Journal of immunology.

[17]  Terry Farrah,et al.  The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.

[18]  O. Febo,et al.  Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.

[19]  T. Takizawa,et al.  Transcription Stimulation of the Fas-encoding Gene by Nuclear Factor for Interleukin-6 Expression upon Influenza Virus Infection (*) , 1995, The Journal of Biological Chemistry.

[20]  J. Kerr,et al.  Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. , 1982, Pathology annual.

[21]  A. Wyllie,et al.  Apoptosis. The role of the endonuclease. , 1990, The American journal of pathology.

[22]  S. Yonehara,et al.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.

[23]  T. LeJemtel,et al.  Pathophysiological Correlates of Increased Serum Tumor Necrosis Factor in Patients With Congestive Heart Failure: Relation to Nitric Oxide‐Dependent Vasodilation in the Forearm Circulation , 1994, Circulation.

[24]  Y. Itoh,et al.  [Determination of serum interleukin-6 concentration by an enzyme-linked immunosorbent assay in patients with paraproteinemia]. , 1992, Rinsho byori. The Japanese journal of clinical pathology.

[25]  C. Caldarera,et al.  Oxygen tension influences DNA fragmentation and cell death in glucocorticoid-treated thymocytes. , 1995, Biochemical and biophysical research communications.

[26]  S. Maruyama.  [Necrosis and apoptosis]. , 1998, Masui. The Japanese journal of anesthesiology.

[27]  M. Lesch,et al.  Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. , 1996, The American journal of pathology.

[28]  T. N. James,et al.  Congenital Disorders of Cardiac Rhythm and Conduction , 1993, Journal of cardiovascular electrophysiology.

[29]  J F Kerr,et al.  Shrinkage necrosis: A distinct mode of cellular death , 1971, The Journal of pathology.

[30]  Takashi Suda,et al.  Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.

[31]  P. Krammer,et al.  Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. , 1995, Blood.

[32]  H. Yagita,et al.  [Metalloproteinase-mediated release of human fas ligand]. , 1996, Nihon rinsho. Japanese journal of clinical medicine.

[33]  I. Behrmann,et al.  Regulation of apoptosis in the immune system. , 1994, Current opinion in immunology.

[34]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[35]  Masato Tanaka,et al.  Expression of the functional soluble form of human fas ligand in activated lymphocytes. , 1995, The EMBO journal.

[36]  A. H. Drummond,et al.  Fas ligand in human serum , 1996, Nature Medicine.

[37]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[38]  J. Kerr,et al.  Patterns of cell death. , 1988, Methods and achievements in experimental pathology.

[39]  M. Lamy,et al.  Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. , 1989, Critical care medicine.